Reagent Proteins, a new division of Pfenex Inc., will be making its conference exhibiting debut at the 10th Annual PepTalk Conference in San Diego next week. In addition, Pfenex Inc. also announced that Dr. Diane Retallack, Director of Molecular Biology, will be a featured speaker at the event.
Representing both Pfenex Inc, and its Reagent Proteins division, Dr. Retallack will be providing a detailed presentation on the rapid production of high quality proteins enabled by the Pfenex Expression Technology platform. Conference attendees are encourage to attend the talk scheduled for Wednesday, January 12, 2011 at 11:45 am as part of the Higher-Throughput Protein Expression, Choosing, Designing, and Optimizing Hosts and Platforms conference track.
The conference will be held at the historic Hotel Del Coronado in San Diego, CA and will feature a select group of speakers from academia and industry. For additional information please visit the Pfenex website.
About Reagent Proteins
Reagent Proteins is a leading supplier of reagent, pre-clinical and cGMP-grade proteins to the biopharmaceutical and vaccine development community. We ensure that scientists have ready access to a comprehensive offering of high-quality proteins to enable their development efforts to proceed efficiently. For more information, please visit www.reagentproteins.com
About Pfenex Inc.
Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information, please visit www.pfenex.com
About Cambridge Health Institute’s PepTalk Conference
CHI’s 10th Annual PepTalk event- a week-long event featuring strong scientific programming comprising fourteen conferences within topic focused pipelines. The four distinct pipelines range from applying protein discovery research, to developing downstream protein expression, characterization, formulation, and production that ultimately leads to clinical applications.